Page 39 - 51 the significance--29.2_opt

References:

1. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet
Med 2008;25(3):245-54.
2. Leiter L, Yale, J-F, Chiasson, J-L, Harris, SB, Kleinstiver, P, Sauriol, L. Assessment of the
impact of fear of hypoglycemic episodes on glycemic and hypoglycemic manage-
ment. Can J Diabetes 2005;29:186-192.
3. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients
with diabetes mellitus and advanced kidney disease. Semin Dial 2004;17(5):365-70.
4. Jung HS, Kim HI, Kim MJ, Yoon JW, Ahn HY, Cho YM, et al. Analysis of hemodialysis-
associated hypoglycemia in patients with type 2 diabetes using a continuous
glucose monitoring system. Diabetes Technol Ther 2010;12(10):801-7.
5. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia
and risks of vascular events and death. N Engl J Med 2010;363(15):1410-8.
6. Nordin C. The case for hypoglycaemia as a proarrhythmic event: basic and clinical
evidence. Diabetologia 2010;53(8):1552-61.
7. Yakubovich N, Gerstein HC. Serious cardiovascular outcomes in diabetes: the role
of hypoglycemia. Circulation 2011;123(3):342-8.
8. Meyer C, Dostou JM, Gerich JE. Role of the human kidney in glucose counterregu-
lation. Diabetes 1999;48(5):943-8.
9. Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesis: its importance
in human glucose homeostasis. Diabetes Care 2001;24(2):382-91.
10. Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced
hypoglycemia in humans. Diabetes 1999;48(2):261-6.
11. Cersosimo E, Garlick P, Ferretti J. Renal substrate metabolism and gluconeogenesis
during hypoglycemia in humans. Diabetes 2000;49(7):1186-93.
12. Woerle HJ, Meyer C, Popa EM, Cryer PE, Gerich JE. Renal compensation for
impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further
evidence for hepatorenal reciprocity. Diabetes 2003;52(6):1386-92.
13. Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin
Dial 2000;13(1):4-8.
14. Rabkin R, Simon NM, Steiner S, Colwell JA. Effect of renal disease on renal uptake
and excretion of insulin in man. N Engl J Med 1970;282(4):182-7.
15. Petersen J, Kitaji J, Duckworth WC, Rabkin R. Fate of [125I]insulin removed from the
peritubular circulation of isolated perfused rat kidney. Am J Physiol 1982;243(2):
F126-32.
16. Rubenstein AH, Mako ME, Horwitz DL. Insulin and the kidney. Nephron 1975;15(3-5):
306-26.
17. Goll K, Lück, G. The insulin half-life as a kidney function test. Z Urol Nephrol 1975;68(12):
927-33.
18. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood
glucose in diabetic patients with renal failure. Diabetes Metab 2000;26 Suppl 4:73-85.
19. Harrower AD. Pharmacokinetics of oral antihyperglycaemic agents in patients with
renal insufficiency. Clin Pharmacokinet 1996;31(2):111-9.
20. Rydberg T, Jonsson A, Roder M, Melander A. Hypoglycemic activity of glyburide
(glibenclamide) metabolites in humans. Diabetes Care 1994;17(9):1026-30.
21. Nye HJ, Herrington WG. Metformin: The Safest Hypoglycaemic Agent in Chronic
Kidney Disease? Nephron Clin Pract 2011;118(4):c380-c383.
22. Preiss DJ, Sattar N. Metformin and lactic acidosis. Metformin: framed again? BMJ
2009;339:b5570.
23. Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad
Sci 2010;1212:12-28.
24. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am
1989;18(1):103-21.
25. Kerr D. Drugs and alcohol. In: Frier B, Fisher B, editors. Hypoglycaemia and Diabetes.
Clinical and Physiological Aspect. London: Edward Arnold; 1993:pp. 328–336.
26. Mak RH, Bettinelli A, Turner C, Haycock GB, Chantler C. The influence of hyperpara-
thyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 1985;60(2):229-33.
27. Mak RH, Turner C, Haycock GB, Chantler C. Secondary hyperparathyroidism and
glucose intolerance in children with uremia. Kidney Int Suppl 1983;16:S128-33.

39